Fusion Pharmaceuticals Inc (FUSN)
21.40
-0.02
(-0.07%)
USD |
NASDAQ |
May 08, 16:00
21.40
0.00 (0.00%)
After-Hours: 20:00
Fusion Pharmaceuticals Cash from Operations (Quarterly): -17.94M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -17.94M |
| September 30, 2023 | -18.84M |
| June 30, 2023 | -19.58M |
| March 31, 2023 | -25.44M |
| December 31, 2022 | -19.36M |
| September 30, 2022 | -21.62M |
| June 30, 2022 | -17.32M |
| March 31, 2022 | -14.97M |
| December 31, 2021 | -16.33M |
| September 30, 2021 | -21.51M |
| Date | Value |
|---|---|
| June 30, 2021 | -17.31M |
| March 31, 2021 | -20.60M |
| December 31, 2020 | -3.082M |
| September 30, 2020 | -12.87M |
| June 30, 2020 | -6.197M |
| March 31, 2020 | -7.62M |
| December 31, 2019 | -3.833M |
| September 30, 2019 | -3.028M |
| June 30, 2019 | -4.001M |
| March 31, 2019 | -2.828M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-25.44M
Minimum
Mar 2023
-3.028M
Maximum
Sep 2019
-14.29M
Average
-17.31M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| AstraZeneca PLC | 2.486B |
| Landos Biopharma Inc | -4.969M |
| Perspective Therapeutics Inc | -9.008M |
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.31M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -5.242M |
| Cash from Financing (Quarterly) | 57.86M |
| Free Cash Flow | -85.69M |
| Free Cash Flow Per Share (Quarterly) | -0.2655 |
| Free Cash Flow Yield | -6.11% |